Helpful Doctors: Wisconsin

According to this article, the top rated Endocrinologists in Milwaukee, WI are:

  • Dr. Diana L. Maas, MD – is an endocrinology, diabetes, and metabolism specialist
  • Dr. Elaine C. Drobny, MD – is board certified in internal medicine and endocrinology
  • Dr. Brent Jones, MD – is an Endocrinology Specialist has over 12 years of experience
  • Dr. Jenna Sarvaideo, DO – specializes in Endocrinology, Diabetes & Metabolism
  • Dr. Betiel F. Voss, MD – is a specialist in endocrinology with over 9 years of experience

Dr. Diana L. Maas, MD

Endocrinologists in Milwaukee

Dr. Diana L. Maas, MD since early 1990, has worked in the field of endocrinology, diabetes, and metabolism. At the Medical College of Wisconsin and Affiliated Hospitals, she earned her medical training and finished her residency and fellowship. Dr. Maas is the Director of the Pituitary Clinic and an Associate Professor of Medicine. She collaborates with neurosurgeons to treat patients with pituitary tumors as a team.

Products/Services:

Endocrinologists

LOCATION:

Address: Froedtert Hospital, 9200 W Wisconsin Ave, Milwaukee, WI 53226
Phone: (414) 805-3666
Websitewww.froedtert.com

REVIEWS:

“My absolute favorite MD. Dr. Maas gets to know her patients and is very thorough. Dr. Maas gave me my life back and I will always love her for that. If you want a great Endocrinologist, she’s your best bet.” – Veronica M.

Dr. Elaine C. Drobny, MD

Top Endocrinologists in Milwaukee

Dr. Elaine C. Drobny, MD is board certified in endocrinology, internal medicine, diabetes, and metabolism. Dr. Drobny graduated from the University of Arizona School of Medicine in 1977 and went on to Northwestern Memorial Hospital in Chicago for her internship and residency in internal medicine. At Northwestern University Hospitals, she completed an endocrinology fellowship. Professional Research Consultants, Inc., a leader in health care research, named Dr. Drobny a “Top Performer” in their 2019 awards, which are based on overall doctor ratings from patient surveys.

Products/Services:

Endocrinologists

LOCATION:

Address: 788 N Jefferson St # 201, Milwaukee, WI 53202
Phone: 
(414) 226-4010
Website: 
www.healthcare.ascension.org

REVIEWS:

“I appreciated the thorough review of all my concerns about my health as it relates to my Osteoporosis and necessary treatment. Also, Dr. Drobny, Nurse & staff are very courteous, pleasant & punctual, very little wait time.” – Elizabeth G.

Dr. Brent Jones, MDEndocrinologists Milwaukee

Dr. Brent Jones, MD is a Milwaukee, Wisconsin-based endocrinology, diabetes, and metabolism specialist with over 12 years of experience. Dr. Jones has greater experience than other physicians in his area with osteoporosis and screening, thyroid disorders, and diabetes and glucose monitoring. In 2009, he received his medical degree from Dartmouth College. Ascension Columbia St. Mary’s Hospital Ozaukee and Ascension Columbia Saint Mary’s Hospital Milwaukee are both affiliated with him. He is now taking new patients and has stated that telemedicine appointments are acceptable.

Products/Services:

Endocrinologists

LOCATION:

Address: 788 N Jefferson St 2ND FLOOR, Milwaukee, WI 53202
Phone: (414) 226-4010
Websitewww.healthcare.ascension.org

REVIEWS:

“Having Dr. Jones as my endocrinologist has made my life with type 1 diabetes the most enjoyable, thankful and grateful since I was diagnosed when I was a young kid. His personality is one to behold. He treats his patients with the utmost respect, and his friendliness is like him being your best friend. I appreciate that very much. I have to thank him for being the one and only doctor who I would choose to help me with my diabetes.” – Patrick Z.

Dr. Jenna Sarvaideo, DOGood Endocrinologists in Milwaukee

Dr. Jenna Sarvaideo, DO practices Endocrinology, Diabetes, and Metabolism in Evanston, as well as four other locations. Northshore University Health System Evanston Hospital, Froedtert & The Medical College Of Wisconsin Community Memorial Hospital Campus, and Froedtert Lutheran Memorial Hospital are all linked with Dr. Sarvaideo.

Products/Services:

Endocrinologists

LOCATION:

Address: 9200 W Wisconsin Ave, Milwaukee, WI 53226
Phone: (414) 805-3666
Websitewww.froedtert.com

REVIEWS:

“Dr. Sarvaideo is incredibly kind and caring and will do whatever she can to help. I’ve seen her for almost 3 years and I recommend her to anyone who is LGBTQ+ and looking to start their journey.” – Niki P.

Dr. Betiel F. Voss MDOne of the best Endocrinologists in Milwaukee

Dr. Betiel F. Voss MD is a specialist in endocrinology in Milwaukee, Wisconsin. In 2012, she received her bachelor’s degree with honors from the University of Texas Medical Branch at Galveston. Dr. Betiel F Voss is affiliated with many hospitals, including Aurora West Allis Medical Center, and Aurora St Lukes Medical Center and collaborates with many other doctors and specialists in the medical group Aurora Medical Group, Inc. Dr. Betiel F Voss has more than 9 years of diverse experience, especially in endocrinology.

Products/Services:

Endocrinologists

LOCATION:

Address: 2801 W Kinnickinnic River Pkwy Ste 260, Milwaukee, WI 53215
Phone: (414) 649-6780
Websitewww.care.aurorahealthcare.org

REVIEWS:

“It’s rare that I go out of my way to review a medical practitioner, but Dr. Betiel Voss deserves special recognition. She’s a caring doctor with a wonderful bedside manner. She offers proactive patient education regarding findings as well. If you’re looking for an endocrinologist, she’s worth the wait.” – Stephanie S.

💉 Did You Get The Pfizer Vaccine? You May Need the Booster

What You Need to Know

COVID-19 Vaccine booster shots are available for the following Pfizer-BioNTech vaccine recipients who completed their initial series at least 6 months ago and are:

Those “underlying medical conditions” include diabetes and obesity.

ℹ️ Basics: Cushing’s Syndrome Overview

Cushing’s syndrome is a rare disorder that occurs when the body is exposed to too much cortisol. Cortisol is produced by the body and is also used in corticosteroid drugs. Cushing’s syndrome can occur either because cortisol is being overproduced by the body or from the use of drugs that contain cortisol (like  prednisone ).

Cortisol is the body’s main stress hormone. Cortisol is secreted by the adrenal glands in response to the secretion of adrenocorticotropic hormone (ACTH) by the pituitary. One form of Cushing’s syndrome may be caused by an oversecretion of ACTH by the pituitary leading to an excess of cortisol.

Cortisol has several functions, including the regulation of inflammation and controlling how the body uses carbohydrates, fats, and proteins. Corticosteroids such as prednisone, which are often used to treat inflammatory conditions, mimic the effects of cortisol.

Stay tuned for more basic info…

❣️The Message Boards Turn 21 Today! ❣️

Today  is the birthday, or anniversary, of the Cushing’s Help message boards.  They were started September 30, 2000 (The rest of the site started earlier that year on July 21, 2000)

As of today, we have 73,130 members who have made countless posts.

Find the message boards here: http://cushings.invisionzone.com/

🎤 4th Pituitary Update | Perelman School of Medicine at the University of Pennsylvania

Friday, October 8, 2021

7:45 am – 4:00 pm

OVERVIEW

This conference will present the newest approaches and techniques in the diagnosis and treatment of pituitary adenomas, including acromegaly and Cushing’s disease. Diagnosis and treatment will be covered from the interdisciplinary and interprofessional perspective of endocrinology, radiology, neuro-ophthalmology, neurosurgery, and radiation oncology. Didactic presentations will include case discussions. The conference format, although virtual will provide a significant opportunity for interaction with expert faculty. A simulcast of transsphenoidal surgery will occur throughout the conference with real-time discussion and case review of the progress on the day of surgery, post-op management, surveillance and follow-up care.

Participants will leave with up-to-date, practical information and written resources including: DDAVP stimulation protocol for Cushing’s disease localization, perioperative glucocorticoid and salt-water monitoring protocol, clinic note templates, laboratory testing panels, “Sick Day Rules” letter for patients with adrenal insufficiency.  These materials will have immediate clinical application and help streamline care of pituitary patients at the office and during hospitalizations.

LEARNING OBJECTIVES – CME

Upon completion of this conference, participants should be able to:

  • Evaluate a sellar mass to determine if it is a pituitary adenoma or other lesion
  • Identify the value and limits of MRI in evaluating a sellar mass
  • List the potential and limits of endoscopic transsphenoidal surgery for pituitary adenoma
  • Manage, medically, a patient following endonasal surgery
  • List the different types of radiation, including linear accelerator (IMRT, Cyberknife), gamma radiation, (Gamma Knife) and proton beam
  • Treat, medically, patients who have acromegaly and Cushing’s disease
  • Apply multidisciplinary, interprofessional and interdisciplinary approach in the management of pituitary disease

LEARNING OBJECTIVES – PATIENTS

  • Upon completion of this course patients, families and advocates will be able to:
  • Identify the latest advances in pituitary tumor treatment
  • Demonstrate familiarity with the terminology and technical aspects of pituitary tumor care
  • Demonstrate patient-active behavior in working with the healthcare team to make ongoing treatment decisions

WHO SHOULD ATTEND

This activity has been designed for endocrinologists, neurosurgeons, ophthalmologists, gynecologists, general radiologists, nurse practitioners, nurses, residents and fellows. Additionally, patients and their caregivers, family members, advocates and members of the public who may benefit from understanding current innovative approaches to pituitary tumor care are invited.

For additional information please contact Hyacen Putmon.

Register Now

💉 Helpful Doctors: New York

Robert Heller, M.D., has joined Albany Med’s Department of Neurosurgery and has been named assistant professor of neurosurgery at Albany Medical College. He specializes in the surgical treatment of pituitary tumors, meningiomas, acoustic neuromas and gliomas. He is also skilled in stereotactic radiosurgery, a precisely targeted form of radiation therapy to treat tumors.

As a cranial and skull base surgeon, Dr. Heller will work with a team comprised of neurosurgeons, radiation oncologists, and ear, nose and throat surgeons who make up Albany Med’s Pituitary and Minimally Invasive Cranial Base Surgery Program.

Dr. Heller completed a complex cranial and skull base neurosurgery fellowship at Tampa General Hospital and University of South Florida in Tampa. He completed his residency training at Tufts Medical Center in Boston, where he also received his medical degree. His research interests include clinical outcomes in minimally invasive approaches to skull base surgery, and he has authored or co-authored nearly two dozen journal articles and book chapters. His professional society memberships include the American Association of Neurological Surgeons and the North American Skull Base Society.

He resides in Delmar.

Dr. Heller is seeing patients at Albany Med’s Department of Neurosurgery at 43 New Scotland Ave. To schedule an appointment or for more information, call the Department of Neurosurgery at (518) 262-5088.

 

 

Media Inquiries:

Sue  Ford Rajchel

fords@amc.edu

(518) 262 – 3421

💉 Dr. Friedman: COVID-19 Vaccine Third Shots vs Booster Shots

Dr. Friedman is getting a lot of emails on booster shots versus third shots. Third shots are for immuno-compromised patients that the FDA is recommending for a small group of patients The FDA also has the intention to soon make booster doses widely available to all healthy individuals. I am writing to clarify the difference between booster shots and third doses.

Third Doses for Immuno-Compromised Patients
The purpose of a third dose of mRNA vaccine is to give immuno-compromised patients the same level of protection that two doses provide someone who has a normal immune system.
It is recommended that the following people get a third dose

  • Been receiving cancer treatment for tumors or cancers of the blood
  • Received an organ transplant and are taking medicine to suppress the immune system
  • Received a stem cell transplant within the last two years or are taking medicine to suppress the immune system
  • Been diagnosed with moderate or severe immunodeficiency conditions (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • An advanced or untreated HIV infection
  • Been under active treatment with high-dose corticosteroids (> 20 mg of prednisone or 100 mg of hydrocortisone) or other drugs that may suppress immune response

Dr. Friedman thinks it is unlikely that any of his patients have these conditions.
Patients with Cushing’s syndrome, Addison’s, diabetes or thyroid disorders do not qualify.

In contrast, a Booster Dose is for Patients With Healthy Immune Systems
A booster dose—which is different from a third dose for immuno-compromised patients—is for healthy patients and is meant to enhance immunity and may protect against new variants of the virus. The Biden administration has announced that it intends to make booster doses available for people with healthy immune systems in September 2021, after they are authorized or approved by the FDA. This has not happened yet, but when it happens, Dr. Friedman would encourage his patients to get it.

Dr. Friedman is expecting a booster shot against the Delta variant to be released in the fall of 2021 and would recommend that for his patients.
Dr. Friedman wishes everyone to stay healthy.

🏆 Last chance to submit a RareVoice Nomination!

 

1) Visit RareVoiceAwards.org

2) Review the 2021 RareVoice categories

3) Nominate an advocate who gave rare disease patients a voice on

Capitol Hill and in state government in 2020 and 2021.

4) Submit!

The RareVoice Awards recipients are chosen by a committee from nominations received from the rare disease community.

 
Nominations close August 27th, 2021
Federal Advocacy – Congressional Staff
Honors congressional staffers who have worked to create and enact policies for the rare disease community

Federal Advocacy – Patient/Organization
Honors advocates or organizations that have worked to create and pass federal legislation

State Advocacy – State Legislator
Honors state legislators who have worked to create and enact policies for the rare disease community

State Advocacy – Patient/Organization
Honors advocates or organizations that have worked to create and pass state legislation

Federal or State Advocacy by a Teenager
Honors teen advocates that have advocated for state or federal legislation

Diversity Empowerment – Patient/Organization
Honors advocates or organizations that empowered diverse voices in advocacy

Artist-to-Advocate
Honors individuals who have utilized their artwork to advocate for federal or state legislation

For information about sponsorship, please contact Elissa Taylor, etaylor@everylifefoundation.org
EveryLife Foundation For Rare Diseases
1012 14th Street, NW, Suite 500 | Washington, District of Columbia 20005
202-697-7273 | info@everylifefoundation.org

🎤 RARE Patient Advocacy Summit

Each year, Global Genes convenes one of the world’s largest gatherings of rare disease patients, caregivers, advocates, healthcare professionals, researchers, partners and allies.

Join us for a variety of interactive and educational events, meet-ups, workshops and networking opportunities. Here you’ll have the opportunity to connect and engage with others in the rare disease community, while experiencing the sense of community and belonging we’ve missed so much. Gain insights about the latest in rare disease innovations, best practices for advocating on an individual and organizational level, and actionable strategies you can implement immediately to accelerate change.

The 2021 RARE Patient Advocacy Summit is a virtual event, happening Monday, September 27, 2021 through Wednesday, September 29, 2021.

2021 RARE Patient Advocacy Summit virtual registration is now open!

Register here: https://web.cvent.com/event/289bd182-abf4-49b0-90be-c2320566c276/regProcessStep1

Speakers: https://globalgenes.org/summit-featured-speakers/

Interested in becoming a speaker? Fill out the speaker inquiry form here.

💉 Dr. Oyesiku to Receive Distinguished Service Award from Society of University Neurosurgeons

The award will presented to Dr. Oyesiku at the Society’s 2021 Annual Meeting August 8-11.


Nelson M. Oyesiku, MD, PhD, FACS, Chair Chair of the UNC School of Medicine Department of Neurosurgery, will receive the Distinguished Service Award given by the Society of University Neurosurgeons at their 2021 Annual Meeting in Whitefish, Montana, August 8-11.

Prior to joining the UNC faculty on April 1, 2021, Dr. Oyesiku was Professor of Neurological Surgery and Medicine (Endocrinology) at Emory University, Atlanta, Georgia and the Inaugural Daniel Louis Barrow Chair in Neurosurgery, Vice-Chairman of the Department of Neurological Surgery and Director of the Neurosurgical Residency Program. Dr. Oyesiku’s clinical expertise is pituitary medicine and surgery. Dr. Oyesiku was co-director of the Emory Pituitary Center and has developed one of the largest practices entirely devoted to the care of patients with pituitary tumors in the country and has performed over 3,700 pituitary tumor operations. Dr. Oyesiku obtained his MD from the University of Ibadan, Nigeria. He obtained an MSc in Occupational Medicine from the University of London, UK and completed a PhD in Neuroscience at Emory University. He completed his Surgery Internship at the University of Connecticut-Hartford Hospital and obtained his neurosurgical training at Emory University, Atlanta. He is board-certified by the American Board of Neurological Surgery. He received an NIH K08 Award and Faculty Development Award from the Robert Wood Johnson Foundation was a recipient of an NIH R01 award and PI of the NIH/NINDS R25 Research Education Program for Residents and Fellows in Neurosurgery. Dr. Oyesiku has served on several NIH Study Sections. Dr. Oyesiku’s research is focused on the molecular pathogenesis of pituitary adenomas, and tumor receptor imaging and targeting for therapy.

Dr. Oyesiku has served on various state, regional, national and international committees for all the major neurosurgical organizations. He has served on the Board of Directors and as Chairman of the American Board of Neurological Surgery. He was on the ACGME-Residency Review Committee of Neurosurgery. He is a Fellow of the American College of Surgeons and has served on its Board of Governors. Dr. Oyesiku has been President of the Congress of Neurological Surgeons. He has served as Secretary/Treasurer and President of the Georgia Neurosurgical Society, President of the Society of University Neurosurgeons, and Vice-President of the American Academy of Neurological Surgeons. He is President of the International Society of Pituitary Surgeons. He is President-Elect of the World Federation of Neurological Surgeons.

Dr. Oyesiku is Editor-in-Chief of NEUROSURGERY, OPERATIVE NEUROSURGERY and NEUROSURGERY OPEN – leading journals in neurosurgery. He is author of over 180 scientific articles and book chapters.

He has been selected by his peers as one of The Best Doctors in America and was selected by the Consumer Research Council of America as one of America’s Top Surgeons. He is named in Marquis Who’s Who in America. He is a member of the Honor Medical Society – Alpha Omega Alpha. He was awarded the “Gentle Giant Award” by the Pituitary Network Association for his services to Pituitary Surgery and Medicine. He is on the Medical Advisory Board of the Cushing’s Support and Research Foundation. He has been visiting professor and invited faculty at several departments of neurosurgery in the United States and abroad.

From https://news.unchealthcare.org/2021/08/oyesiku-to-receive-distinguished-service-award-from-society-of-university-neurosurgeons/